A Web-Based Multimedia Resource for Prescription Opiate Treatment

描述（由申请人提供）：基于网络的处方阿片类药物治疗多媒体资源：流行病学数据清楚地表明，处方阿片类药物的滥用是一个主要的公共卫生问题。丁丙诺啡是一种重要的药物，对治疗依赖处方阿片类药物的人有很大的希望。人们普遍认为丁丙诺啡的成功治疗包括丁丙诺啡和社会心理咨询/治疗支持的结合。然而，越来越多的证据表明，许多服用丁丙诺啡治疗的处方阿片类药物成瘾者并没有参加任何形式的咨询或治疗。不参加咨询和治疗的原因包括此类服务的成本增加，难以获得了解丁丙诺啡使用的咨询专业人员，以及找时间参加治疗计划的后勤挑战。世界之眼媒体集团（EOW）与加州大学洛杉矶分校综合药物滥用计划（ISAP）合作，提议开发一种创新的基于网络的资源，以增加丁丙诺啡对处方阿片类药物使用者的治疗。本应用程序建议开发处方药物滥用内部（IPDA），一个基于网络的处方阿片类药物治疗多媒体资源。IPDA利用互联网技术的最新进展，将交互式视频模块、流媒体视频/动画片段、测验、在线论坛和其他资源汇集在一个定制的网站上，使参与者能够控制何时、何地以及如何体验与治疗相关的内容。这些媒体工具将传达有吸引力的、科学准确的信息，提供基于认知行为治疗原则的行为治疗练习，并通过互动反馈和参与工具促进康复活动。项目团队将结合由Emily Meyers （MBA）和Marisa Murgatroyd （MA）领导的EOW的媒体专业知识，以及由Larissa Mooney （MD）领导的UCLA ISAP的成瘾专家团队。该团队将开发内容、视频和网站应用程序，为丁丙诺非治疗患者创建一个独特的资源。将从两个重要的潜在消费者群体，丁丙诺啡处方md （N=50）和目前正在接受丁丙诺啡治疗的患者（N=50）收集有关IPDA资源价值的数据。数据将通过焦点小组、评级量表和问卷收集，包括IPDA资源的可用性、网站上呈现的材料的相关性和准确性、创新视频场景的吸引力和益处，以及对定价、营销和推广工作的反馈。多媒体Web平台的使用是一种创新，并且有证据表明这种产品具有商业前景。在第一阶段项目取得成功之后，将对IPDA进行第二阶段对照试验评价。

DESCRIPTION (provided by applicant): A Web-Based Multimedia Resource for Prescription Opiate Treatment: Epidemiological data clearly indicate that the abuse of prescription opiates is a major public health problem. Buprenorphine is an important medication that offers great promise in treating individuals who have become dependent on prescription opiates. It is widely accepted that successful treatment with buprenorphine involves a combination of buprenorphine and psychosocial counseling/therapy support. However, there is growing evidence that many individuals addicted to prescription opiates who are being treated with buprenorphine do not participate in any form of counseling or therapy. Reasons cited for non-participation in counseling and therapy include added cost of such services, difficulty in accessing counseling professionals with knowledge about the use of buprenorphine, and logistical challenges in finding time to attend therapy programs. Eyes of the World Media Group (EOW), in collaboration with UCLA Integrated Substance Abuse Programs (ISAP), proposes to develop an innovative Web-based resource to augment buprenorphine treatment of prescription opiate users. This application proposes to develop Inside Prescription Drug Abuse (IPDA), a Web- based multimedia resource for prescription opiate treatment. IPDA uses recent advances in Internet technology to bring together interactive video modules, streaming video/animation segments, quizzes, an online forum, and other resources in a customized Website that allows participants to control when, where, and how they experience treatment-related content. These media tools will convey engaging, scientifically accurate information, provide behavioral treatment exercises based on cognitive behavioral therapy principles, and promote recovery activities via interactive feedback and engagement tools. The project team will combine the media expertise of EOW led by Emily Meyers, MBA, and Marisa Murgatroyd, MA, with a team of addiction experts from UCLA ISAP led by Larissa Mooney, MD. This team will develop the content, video, and Website applications to create a unique resource for patients in buprenorphine treatment. Data will be collected on the value of the IPDA resource from two important potential consumer groups, buprenorphine-prescribing MDs (N=50) as well as patients (N=50) currently in treatment with buprenorphine. Data will be collected via focus groups, rating scales, and questionnaires on the perceived usefulness of the IPDA resource, the relevance and accuracy of the material presented on the site, the appeal and benefit of the innovative video scenarios, and feedback on pricing, marketing, and promotion efforts. The use of the multimedia Web platform is innovative, and there is evidence of commercial promise with such a product. A Phase II controlled trial evaluation of IPDA would follow a successful Phase I project. PUBLIC HEALTH RELEVANCE: The development of an accessible and cost-effective Web-based resource to augment the buprenorphine treatment of individuals dependent on prescription opiates will improve the treatment response of this patient group and reduce the morbidity and mortality associated with prescription opiate addiction. This intervention allows patients in buprenorphine treatment access to a set of Web-based multi-media resources comprising interactive videos, animations, quizzes, customized feedback tools, and other resources promoting (a) knowledge and skills consistent with the principles of cognitive behavioral therapy, (b) the benefits of buprenorphine, and (c) other important addiction knowledge to support positive recovery activities. If successful, the product has the potential to reduce significant geographic, temporal, and financial barriers to psychosocial support; provide critical behavioral and addiction knowledge; and improve the treatment outcomes of thousands of opioid-dependent individuals.